default author photo

Roberta Rudà

University of Turin

Via Po 53

Torino, Turin - Piedmont 10100

Italy

SCHOLARLY PAPERS

1

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

Number of pages: 34 Posted: 10 Sep 2018
Giuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, Marica Eoli, Roberta Rudà, Marina Faedi, Ivan Lolli, Andrea Pace, Bruno Daniele, Francesco Pasqualetti, Simona Rizzato, Ardi Pambuku, Luisa Bellu, Miriam Farina, Giovanna Magni, Stefano Indraccolo, Marina Paola Gardiman and Vittorina Zagonel
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Department of Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Fondazione IRCCS Istituto Neurologico ‘Carlo Besta’, University of Turin, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Azienda Ospedaliera G. Rummo, Azienda Ospedaliera-Universitaria Pisana, Azienda Sanitaria-Universitaria Integrata, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Department of Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Department of Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), University of Padua - Padua General University Hospital and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Department of Oncology
Downloads 77 (830,555)

Abstract:

Loading...

glioblastoma; regorafenib; lomustine; recurrent glioblastoma